Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Gaia Bianco, Mairene Coto‐Llerena, John Gallon, Venkatesh Kancherla, Stephanie Taha‐Mehlitz, Mattia Marinucci, Martina Konantz, Sumana Srivatsa, Hesam Montazeri, Federica Panebianco, Vijaya G. Tirunagaru, Marta De Menna, Viola Paradiso, Caner Ercan, Ahmed Dahmani, Élodie Montaudon, Niko Beerenwinkel, Marianna Kruithof‐de Julio, Luigi Terracciano, Claudia Lengerke, Rinath Jeselsohn, Robert C. Doebele, François‐Clément Bidard, Elisabetta Marangoni, Charlotte K.y. Ng, Salvatore Piscuoglio, Riccardo Murri, Lucas PelkmansCommunications 2022 · DOI · OpenAlex

BibTeX
@inproceedings{bianco2022author,
  author = {Gaia Bianco and Mairene Coto‐Llerena and John Gallon and Venkatesh Kancherla and Stephanie Taha‐Mehlitz and Mattia Marinucci and Martina Konantz and Sumana Srivatsa and Hesam Montazeri and Federica Panebianco and Vijaya G. Tirunagaru and Marta De Menna and Viola Paradiso and Caner Ercan and Ahmed Dahmani and Élodie Montaudon and Niko Beerenwinkel and Marianna Kruithof‐de Julio and Luigi Terracciano and Claudia Lengerke and Rinath Jeselsohn and Robert C. Doebele and François‐Clément Bidard and Elisabetta Marangoni and Charlotte K.Y. Ng and Salvatore Piscuoglio and Riccardo Murri and Lucas Pelkmans},
  title = {{Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers}},
  booktitle = {Communications},
  year = {2022},
  doi = {10.1038/s42003-022-03612-5},
}

Loading related content...

Figure